Janus Henderson Group
SGMO

Janus Henderson Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Janus Henderson Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-56,831
Closed -$99.7K – 2655
2023
Q1 		$99.7K Buy
56,831
+32,100
+130% +$91.6K ﹤0.01% 2616
2022
Q4 		$77.5K Sell
24,731
-24,731
-50% -$96K ﹤0.01% 2375
2022
Q3 		$244K Buy
49,462
+24,633
+99% +$127K ﹤0.01% 2303
2022
Q2 		$103K Buy
24,829
+108
+0.4% +$467 ﹤0.01% 2467
2022
Q1 		$143K Buy
24,721
+8
+0% +$48 ﹤0.01% 2509
2021
Q4 		$185K Buy
24,713
+12,428
+101% +$108K ﹤0.01% 2414
2021
Q3 		$111K Buy
+12,285
New +$121K ﹤0.01% 2142

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group's SGMO Position: Q2 2023 in Review

Janus Henderson Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 56,831 shares — an estimated $99.7K sold.

Janus Henderson Group first reported a position in SGMO in Q3 2021 and held it in 7 quarters. The position peaked at $244K in Q3 2022. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • Janus Henderson Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • Janus Henderson Group sold 56,831 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $99.7K.
  • Janus Henderson Group first reported a position in SANGAMO THERAPEUTICS INC in Q3 2021 and held it in 7 quarters.
  • Janus Henderson Group's SANGAMO THERAPEUTICS INC position peaked at $244K in Q3 2022.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.